123 related articles for article (PubMed ID: 11352259)
1. Microchimerism in Japanese patients with systemic sclerosis.
Ichikawa N; Kotake S; Hakoda M; Kamatani N
Arthritis Rheum; 2001 May; 44(5):1226-8. PubMed ID: 11352259
[No Abstract] [Full Text] [Related]
2. Microchimerism in Japanese women patients with systemic sclerosis.
Murata H; Nakauchi H; Sumida T
Lancet; 1999 Jul; 354(9174):220. PubMed ID: 10421308
[TBL] [Abstract][Full Text] [Related]
3. [Clinical, serological and immunogenetic studies of systemic sclerosis: a French response to the paper of JP Maddison].
Meyer O
Rev Rhum Mal Osteoartic; 1991 May; 58(5):371-3. PubMed ID: 1647545
[No Abstract] [Full Text] [Related]
4. Y chromosome microchimerism in rheumatic autoimmune disease.
Miyashita Y; Ono M; Ono M; Ueki H; Kurasawa K
Ann Rheum Dis; 2000 Aug; 59(8):655-6. PubMed ID: 10991761
[No Abstract] [Full Text] [Related]
5. Antibody response to pneumococcal polysaccharide vaccine in systemic sclerosis.
Mercado U; Acosta H; Diaz-Molina R
J Rheumatol; 2009 Jul; 36(7):1549-50. PubMed ID: 19567636
[No Abstract] [Full Text] [Related]
6. [Autoantibodies in systemic sclerosis (scleroderma)].
Greenbaum E; Laufer M; Shoenfeld J
Harefuah; 1993 Mar; 124(6):370-4. PubMed ID: 8388360
[No Abstract] [Full Text] [Related]
7. Immunoblotting on HEp-2 cells increases the detection of antitopoisomerase 1 antibodies in patients with systemic sclerosis.
Tamby MC; Servettaz A; Guilpain P; Tamas N; Berezné A; Batteux F; Reinbolt J; Guillevin L; Weill B; Mouthon L
Clin Immunol; 2007 Apr; 123(1):82-8. PubMed ID: 17258939
[TBL] [Abstract][Full Text] [Related]
8. Juvenile systemic sclerosis: report of three cases and review of Japanese published work.
Aoyama K; Nagai Y; Endo Y; Ishikawa O
J Dermatol; 2007 Sep; 34(9):658-61. PubMed ID: 17727371
[TBL] [Abstract][Full Text] [Related]
9. Pathogenic autoantibodies in systemic sclerosis.
Gabrielli A; Svegliati S; Moroncini G; Avvedimento EV
Curr Opin Immunol; 2007 Dec; 19(6):640-5. PubMed ID: 18083509
[TBL] [Abstract][Full Text] [Related]
10. IgG reactivity with a 100-kDa tissue and endothelial cell antigen identified as topoisomerase 1 distinguishes between limited and diffuse systemic sclerosis patients.
García de la Peña-Lefebvre P; Chanseaud Y; Tamby MC; Reinbolt J; Batteux F; Allanore Y; Kahan A; Meyer O; Benveniste O; Boyer O; Guillevin L; Boissier MC; Mouthon L
Clin Immunol; 2004 Jun; 111(3):241-51. PubMed ID: 15183145
[TBL] [Abstract][Full Text] [Related]
11. [Coexistence of antitopoisomerase I and anticentromere antibodies in systemic sclerosis].
Garrido Rasco R; Castillo Palma MJ; García Hernández FJ; Sánchez Román J
Med Clin (Barc); 2010 Sep; 135(9):430-1. PubMed ID: 19767035
[No Abstract] [Full Text] [Related]
12. Antitopoisomerase and anticentromere antibodies in the sclerodermatosus complex.
Kallenberg CG
Clin Rev Allergy; 1994; 12(3):221-35. PubMed ID: 7804956
[No Abstract] [Full Text] [Related]
13. Microchimerism and autoimmune disease.
Nelson JL
N Engl J Med; 1998 Apr; 338(17):1224-5. PubMed ID: 9554866
[No Abstract] [Full Text] [Related]
14. HLA-DQA1 is not an apparent risk factor for microchimerism in patients with various autoimmune diseases and in healthy individuals.
Artlett CM; O'Hanlon TP; Lopez AM; Song YW; Miller FW; Rider LG
Arthritis Rheum; 2003 Sep; 48(9):2567-72. PubMed ID: 13130476
[TBL] [Abstract][Full Text] [Related]
15. Feto-maternal microchimerism in connective tissue diseases.
Gannagé M; Amoura Z; Lantz O; Piette JC; Caillat-Zucman S
Eur J Immunol; 2002 Dec; 32(12):3405-13. PubMed ID: 12432571
[TBL] [Abstract][Full Text] [Related]
16. [Low prevalence of anti-centromere antibodies in scleroderma in Morocco (about 272 cases)].
Admou B; Arji N; Seghrouchni F; Missoum H; El Fenniri L; Amghar S; El Aouad R
Ann Biol Clin (Paris); 2007; 65(3):291-7. PubMed ID: 17502303
[TBL] [Abstract][Full Text] [Related]
17. Anti-topoisomerase I autoantibodies in systemic sclerosis.
Czömpöly T; Simon D; Czirják L; Németh P
Autoimmun Rev; 2009 Jul; 8(8):692-6. PubMed ID: 19393194
[TBL] [Abstract][Full Text] [Related]
18. Antibodies to topoisomerase I in sera from patients with scleroderma.
Shero JH; Bordwell B; Rothfield NF; Earnshaw WC
J Rheumatol Suppl; 1987 Jun; 14 Suppl 13():138-40. PubMed ID: 3039129
[TBL] [Abstract][Full Text] [Related]
19. [Microchimerisme in systemic sclerosis].
Aractingi S; Regnier S
Ann Med Interne (Paris); 2002 May; 153(3):189-91. PubMed ID: 12218902
[TBL] [Abstract][Full Text] [Related]
20. Elevation of IgG levels is a serological indicator for pulmonary fibrosis in systemic sclerosis with anti-topoisomerase I antibodies and those with anticentromere antibody.
Komura K; Yanaba K; Ogawa F; Shimizu K; Takehara K; Sato S
Clin Exp Dermatol; 2008 May; 33(3):329-32. PubMed ID: 18312458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
